chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initially, no immediate problems other than slightly tender at injection site. Approximately 48 hours later (evening 01/14/2021) started to notice increased inflammation about the size of a "quarter" on left side of chin. I did have a pimple/ingrown hair at this site prior to the injection which was mostly healed but not entirely healed. The next morning, 01/15/2021, I experience mild facial numbness to the left side of my chin and mild facial paralysis resulting in an asymmetrical smile, and mild swelling to the left side of my face. Two day later (morning 01/17/2021) with my symptoms not worsening but showing only a little improvement, I went to my local urgent care for evaluation. Provider was not 100% sure of the diagnosis but felt this could be a case of shingles or folliculitis. I was treated with a 7 day course of acyclovir and a 10 day course of doxycycline hyclate. The numbness subsided 2-3 days after treatment began. The facial paralysis and swelling showed much improvement (90-95%) after completing the acyclovir on 01/24/2021; however, I feel there is still a little more improvement to go.
POOR VISION; DOUBLE VISION; BLURRED VISION; This spontaneous report received from a patient concerned an 80 year old female. The patient's height, and weight were not reported. The patient's past medical history included cataract surgery on left eye. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 to left arm for prophylactic vaccination. Concomitant medications included influenza vaccine for prophylactic vaccination.  On 12-MAR-2021, the subject experienced poor vision. On 12-MAR-2021, the subject experienced double vision. On 12-MAR-2021, the subject experienced blurred vision. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from poor vision, double vision, and blurred vision. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment not required per standard procedure as the case is assessed as non-serious.
Pt broke out in hives face to legs 1 1/2 hour after receiving MMR II vaccine. Parent went to daycare, did confirm hives with moderate wheezing. BENADRYL given and Pt watched for an hour.
Blood pressure 151/120; Started getting very clammy then my left arm and leg was kicking on their own; Started getting very clammy then my left arm and leg was kicking on their own; Then two nights later had very bad stomach cramping; Diarrhea all night; This is a spontaneous report from a contactable consumer or other non Healthcare professional (patient, reported for self). A 53-years-old (non-pregnant) female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: ER2613 31Jul2021), via an unspecified route of administration, administered in Arm Right at the age of 53-year-old on 25Mar2021 12:00 as dose 1, single for COVID-19 immunization. Medical history included multiple myeloma-stem cell transplant. Concomitant medication(s) (List of other medications the patient received within 2 weeks of vaccination) included pregabalin (LYRICA) taken for an unspecified indication, start and stop date were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 12:00 the patient Started getting very clammy then her left arm and leg was kicking on their own. Blood pressure was 151/120 (units not reported). Then two nights later had very bad stomach cramping and diarrhea all night (medically significant). Since the vaccination, the patient had not been tested for COVID-19. The patient underwent lab tests and procedures which included blood pressure measurement: 151/120 on 25Mar2021 Blood pressure 151/120. The patient received treatment with Benadryl. The clinical outcome of the events was reported as recovering.  Follow-Up (14Jul2021): Follow-up attempts are completed. No further information is expected.
pt received second dose of pfizer vaccine and within ten minutes started feeling dizzy and nauseated, sweating and feeling as though having a panic attack. Pt had syncope episode and ammonia inhalant used and pt non responsive. 911 called and pt monitored. Once pt placed on stretcher pt became more responsive and was able to state name and todays date,  bp 109/62 p73 @ 15:48 / bp 109/74 p 88 @ 15:52. Pt verbal and states he is feeling better, states he has not had much to drink today and has been mowing today. EMS on scene and pt leaves clinic with EMS.
Fever; body aches; arm very sore; This is a spontaneous report from a contactable consumer. This 59-year-old Male consumer reported that.  A 59-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: En6203), dose 1 via an unspecified route of administration, administered in Arm Left on 04Mar2021 15:30 as (At the age of 59-years) dose 1, single for covid-19 immunisation. No other medical history was reported, and Patient received other medications (Not specified) in two weeks. It was Unknown if covid prior vaccination. No covid tested post vaccination. No known allergies ware reported. No other vaccine in four weeks. The patient experienced fever, body aches, arm very sore on 04Mar2021 05:00. Patient did not receive any other treatment for events.  No follow-up attempts are possible. No further information is expected.
Wheezing, Extreme Dizziness (ongoing), Runny Nose, Joint pain. The dizziness is severe enough that I am unable to drive, and I NEVER miss a day of work (until now).
A few minutes after patient got vaccinated. Pt states having rapid heart beat and nausea. Paramedics arrived. Pt has tachycardia and anxiety.  Patient had breast cancer 2019. Currently taking Tamoxifen  Tachycardia 120  Bp 155/107 Vitals improved to HR 94 Bp 137/100  Monitor patient for another 20 min  Pt stable
Information has been received from a nurse concerning a colleague, a 44 year old white female registered nurse who on 29-AUG-2007, was accidentally squirted in the left eye with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella  virus vaccine live (Wistar RA 27/3) (lot number 655270/1409F). She experienced burning, redness, and a dull ache on the left eye, and her lower eye lid was puffy. Additionally, she reported aches on the left wrist, left hand and left arm. She believed this was due to the malfunction of the needle and syringe (that the needle dissembled from the hub) during the withdrawing of the vaccine from the original vial. A the time of this report she has not sought medical attention but will be checked (date not specified) by her employee health department. No product quality complaint was reported. No further information was available. Follow-up information received from the consumer noted the patient has no known allergies, a history of mumps and measles as a child and was revaccinated for (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (manufacturer unknown) in 2001 for nursing school. On 04-SEP-2007 the patient experienced blurred vision of the left eye and pain (duration 3 weeks). It was reported the patient was administering the vaccine to a child when drawing up the vaccine the syringe and needle came apart at the hub and the MMR solution was sprayed into the patient's left eye and facial area. The patient rinsed her eye immediately after incident. Additional information is not expected.
Administered vaccine at 1:33 PM into RD Deltoid patient fainted at 1:36 PM after administration of Vaccine. Nurse practitioner assessed patient Vitals Taken 1:36 PM Blood Pressure: 112/80mmhg  Pulse: 62  Sp02: 100%. Observed patient for additional 15 Minutes per provider. Vital retaken at 2:10 PM  Blood pressure: 90/60mmhg Pulse: 63 Spo2: 100% . Per provider okay to release home . Notified if symptoms worsen go to nearest emergency room and/or contact his Primary Care, if needed. patient verbalized understanding and agreed (Note: per patient he has a history of Fainting (syncope)  due to needle phobia)
Last menstrual period either Nov 1-8 (light, abnormal, pregnancy symptoms) or Nov 29-12/2 (light, abnormal, pregnancy symptoms).  Possible dates of conception 10/16, 10/18, 10/19, 11/14, 11/15.  Negative pregnancy test on 11/26 & 11/29.  +Pregnancy test 12/10.   Estimated delivery dates were either 7/8/21 or 8/8/21. First covid vaccine received on 12/30.  First OB ultrasound on 1/5/21, estimated to be 6 weeks + 3 days gestation, with no heartbeat.  Repeat ultrasound on 1/13/21, continued to measure 6 weeks + 3 days gestation, again with no heartbeat. Spontaneous miscarriage did not occur, 1 time dose of intravaginal Cytotec was taken and medical abortion completed.
RASH (IN CREASES OF HIS ARM, BUTTOCK AND GROIN AREA); MILD FEVER; BODY ACHES (SORENESS); This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and expiry: UNKNOWN) dose was not reported, administered on 22-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 22-JUN-2021, the subject experienced body aches (soreness). On 22-JUN-2021, the subject experienced mild fever. On 23-JUN-2021, the subject experienced rash (in creases of his arm, buttock and groin area). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from rash (in creases of his arm, buttock and groin area), and the outcome of mild fever and body aches (soreness) was not reported. This report was non-serious.
allergic contact dermatitis; Got a second rash; it didn't itch until 2 or 3 days later and lasted for; got a rash, like overheated/broke out on chest| left arm| collarbone| a little bit on shoulder| base of neck| started to hit the right arm/second rash; got a rash like overheat; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of MILIARIA (got a rash like overheat), DERMATITIS CONTACT (allergic contact dermatitis), RASH (got a rash, like overheated/broke out on chest| left arm| collarbone| a little bit on shoulder| base of neck| started to hit the right arm/second rash), RASH (Got a second rash) and RASH PRURITIC (it didn't itch until 2 or 3 days later and lasted for) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058H21A, 038B21A and 001B21A) for COVID-19 vaccination.     The patient's past medical history included Rash all over (Patent have a history of rashes on her full body.), Heat rash and Rash on leg.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced MILIARIA (got a rash like overheat), RASH (got a rash, like overheated/broke out on chest| left arm| collarbone| a little bit on shoulder| base of neck| started to hit the right arm/second rash) and RASH PRURITIC (it didn't itch until 2 or 3 days later and lasted for). In April 2022, the patient experienced RASH (Got a second rash). On an unknown date, the patient experienced DERMATITIS CONTACT (allergic contact dermatitis). The patient was treated with TRIAMCINOLONE for Rash, at an unspecified dose and frequency; HYDROXYZINE HCL in April 2022 for Antihistamine therapy, at a dose of 25 milligram and DESOXIMETASONE in April 2022 for Antihistamine therapy, at an unspecified dose and frequency. At the time of the report, MILIARIA (got a rash like overheat), DERMATITIS CONTACT (allergic contact dermatitis) and RASH (Got a second rash) outcome was unknown and RASH (got a rash, like overheated/broke out on chest| left arm| collarbone| a little bit on shoulder| base of neck| started to hit the right arm/second rash) and RASH PRURITIC (it didn't itch until 2 or 3 days later and lasted for) had resolved.            Concomitant medication included Triamcinolone cream 0.1 %. It was reported that rash did not itch until 2 or 3 days later and lasted for about a month  Dermatologist prescribed hydroxyzine hcl 25mg tablet, antihistamine and desoximetasone 0.25% cream an diagnosed with allergic contact dermatitis.
rash / diffuse maculopapular rash over torso, back and upper extremities as well as lower extremities; This case was reported by a physician via call center representative and described the occurrence of maculopapular rash in a 26-year-old male patient who received HBV (Engerix B adult) (batch number J2J9R, expiry date 14th September 2021) for prophylaxis.   On 25th March 2019, the patient received the 1st dose of Engerix B adult (intramuscular). On 27th March 2019, 2 days after receiving Engerix B adult, the patient experienced maculopapular rash. On an unknown date, the outcome of the maculopapular rash was unknown.   It was unknown if the reporter considered the maculopapular rash to be related to Engerix B adult.  Additional details were provided as follows: The age at vaccination was not reported but it could be 25 years or 26 years. The patient experienced diffuse maculopapular rash over torso, back and upper extremities as well as lower extremities. The patient did not experience rash on palms or soles of feet or mucosa.
Anxious, nervous, dehydrated, a lot of pain in left arm lasted for about 5 days. I called clinic but was told to wait and to contact VAERS.
Persistent headache; This is a spontaneous report received from contactable reporter(s) (Physician).  A male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Persistent headache".' Additional information: Patient was upset about experiencing new daily persistent headache after a COVID19 vaccination from Pfizer.   Follow-up attempts are completed. No further information is expected.
aching; allergies; This is a spontaneous report from a contactable consumer.     A 73-years-old female patient received first bnt162b2 (BNT162B2), via an unspecified route of administration on 06Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Patient scheduled on Saturday 27Feb2021 for second dose. Medical history included arthritis from an unknown date and unknown if ongoing inflammation from arthritis and take ibuprofen for inflammation. The patient's concomitant medications were not reported.  The patient experienced aching on an unspecified date with outcome of unknown, allergies (hypersensitivity) on an unspecified date with outcome of unknown.    Information about Lot/Batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Case number PHEH2014US024163 is an initial spontaneous report received from a health care professional on 01 Dec 2014. This report refers to a 16 years old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: A13046) intramuscularly at a dose of 0.5 ml on 13 Nov 2014. It was reported that the vaccine reached 0 to 1 degree C sporadically for 3 days when it was not reconstituted and was subsequently administered to the patient. The reporter stated that the vaccine did not freeze and it was the first occurrence. No adverse events were reported following the maladministration.
Severe headaches since the vaccination.  Visited, urgent care, ER, and physician, with no substantial treatment.
Palpitations, perioral "tingling" and "tongue thickness", shortness of breath.
1 hour after receiving PNEUMOVAX patient developed severe left arm pain and swelling, was admitted to Hospital, CT showed extensive fat stranding consistent with inflammation and possible infection. Note that pt had experienced similar but milder sx after receiving PCV-13 in April 2017. This history suggests an allergic reaction (not infection) because of the previous sx and the rapid onset of sx after vaccine administration.
Follow up information received provided concomitant vaccination information. Information regarding Prevnar was received from a nurse regarding a 5 month old male patient who experienced pneumococcal septicemia. At 4 months of age, the patient received the second dose on 1/9/04. Relevant medical history was not provided. Indication for Prevnar was immunization. Product was administered on 1/9/04. Dose regimen was 1 dose (IM). Concomitant vaccines included Tripedia, Comvax, and IPOL. On 2/18/04, the infant was hospitalized for pneumococcal septicemia. A blood culture was performed; Streptococcus pneumoniae was isolated. Laboratory tests performed on an unspecified date revealed a white blood cell count of 15,000 and a C-reactive protein of 6.9. The infant received a three-day course of unspecified IV antibiotics. On 2/21/04, he was discharged from the hospital on unspecified oral medications. He recovered. No additional information was available at the time of this report.
Vaccinated occurred at 1:55 pm March 26, 2021. At approximately 8:30am March 27, I began an episode of Transient Global Amnesia, an I was hospitalized to rule out a stroke.
This spontaneous report as received from a registered nurse via office manager refers to a 12 month old female patient. The patient's concurrent conditions and medical history were not reported. On 21-APR-2016, the patient was vaccinated with a first dose of (Merck) VARIVAX lot # L035127, expiry date 14-SEP-2017 (route and site of administration were not reported, which had previously undergone a supported temperature excursion. Concomitant therapies included MMR II. It was unknown if there was any relevant laboratory data. This is one of three reports received from the same reporter. Additional information has been requested.
pt had a swollen shoulder and pain shortly after the shot.  pt went to er on Sun 9/20.  pt got an xray an unltrasound and they aspirated fluid.  pt was told she has bursitis.  pt was released on no other med or instruction.  pt came to pharmacy on 9/23 to alert us to the issue.  pt is doing better but still has some residual pain.
big itching in the body/strong itching; pain in the back and stomach/hurts in her upper back; pain in the back and stomach/hurts in front of her upper stomach; broke out in rash all over her body; This is a spontaneous report from a contactable consumer or other Non-health care professional.   An 80-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 25Jan2021 as 2ND DOSE, SINGLE for indication of COVID-19 immunization. The patient medical history was not reported. The patients concomitant medications were not reported. The following 4 days patient was fine and after that she described her side effects as big itching in the body, pain in the back and stomach - She went to Hospital and doctors were not able to give any treatment recommendations. She wants to consult with Pfizer about her condition and seek for recommendations. patient broke out in rash all over her body and she was concerned about it. Patient stated that she had a strong itching for three days. Reported that hurts upper back and front of upper stomach. Has insurance and no one answered what she needs. Stated that she is in the shower every half hour. Stated that the itching is bad and she wanted to know what to do. Stated that she is healthy and has no problems and she had the vaccine a week ago and did not have any symptoms until three days ago when the itching started very hard then her back thing and then her stomach thing. Stated that she had no symptoms from the first one. Patient had taken her second dose of vaccine a week ago and did not have any symptoms until three days ago when she experienced, strong itching (pruritis), hurts in her upper back/front of her upper stomach (abdominal pain upper), rash all over her body. Stated that she called Medical Information before and they did nothing. Case number not provided. Outcome of events was unknown.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
LEG CLOT; SICK; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported ,1 in total administered for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced leg clot and sick. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of leg clot and sick was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210526445 and 20210525676.; Sender's Comments: V0:20210526416  -Covid-19 vaccine ad26.cov2.s- Thrombosis - This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
about 3-4 weeks after the vaccine I started get sick starting with gas head cold, restricted breathing and upper respiratory problems that would last for about a week this has been repeated every other week since march of 2021
was turned up sick; Initial information was received on 08-Nov-2020 regarding an unsolicited valid non-serious social media case from a consumer via Social media.  This case involves patient (unknown demography) who was turned up sick (illness), while the patient received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious was turned up sick (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
2:30 pm Patient complaint of foggy head, headache, flushed feeling, sweaty, dry mouth, jaw felt "weird",   2:30 pm BP 150/76, pulse ox 100%, pulse 76  2:55 pm BP 166/104 pulse Ox 99%, pulse 76 and complaint of feeling short of breath. No improvement of symptoms, 911 was called